Posts by: Mary Chapman

News

Takeda Oncology has launched a mentorship program aimed at empowering and encouraging multiple myeloma patients and caregivers throughout their disease journey. Called My Mentor Connections, the program enlists caregivers ... Read more

May 10, 2019

OncLive Poised to Induct 2019 Class of ‘Giants of Cancer Care’

News

OncLive, a digital resource platform for oncologists, will welcome 15 new members at its 7th Annual Giants of Cancer Care Winners Reception on May 30 in Chicago, Illinois. Inductees are ... Read more

May 1, 2019

bluebird bio Opens Manufacturing, Research Facility in Durham, N.C.

News

Bluebird bio has officially opened a facility in Durham, North Carolina, to make the lentiviral vector needed for its investigational gene and cell treatments, including the CAR T-cell therapies bb2121 and bb21217 ... Read more

April 24, 2019

MMRF Launches Fund to Invest in Innovative Firms for Multiple Myeloma Research

News

The Multiple Myeloma Research Foundation (MMRF) has launched the Myeloma Investment Fund in an effort to attract promising biotech and technology companies to the multiple myeloma field and to advance ... Read more

March 1, 2019

It’s Off to the Races for eRace Cancer’s 78-year-old Founder and Multiple Myeloma Survivor

News

In 2003, Don Wright received a daunting diagnosis of multiple myeloma. But not only has the 78-year-old survived, he has thrived. He’s since run 100 marathons, and is preparing for ... Read more

February 25, 2019

International Myeloma Foundation Gears Up for March, Myeloma Action Month

News

To raise awareness of multiple myeloma and efforts to cure it, the International Myeloma Foundation (IMF) is gearing up for the start of Myeloma Action Month (MAM) on March 1. ... Read more

February 22, 2019February 25, 2019

Multiple Myeloma Research Foundation Makes Changes in Leadership to Advance Precision Medicine

News

The Multiple Myeloma Research Foundation (MMRF) is growing and adjusting its executive team, with a focus on improving multiple myeloma patient outcomes and advancing its precision medicine program. Steve Labkoff, ... Read more

February 15, 2019

$75M Gift to Establish Center for Blood Cancers at NYU Langone Health Center

News

Owing to an anonymous $75 million gift, New York University (NYU) Langone Health and its Laura and Isaac Perlmutter Cancer Center will establish a Center for Blood Cancers. The ... Read more

February 6, 2019

Donation Will Establish Center for Multiple Myeloma Research in UK

News

Thanks to a £10 million donation (about $13,000,000), Imperial College London will establish a center for multiple myeloma research at the institution’s Hammersmith Hospital campus. The gift, from benefactors Hugh ... Read more

January 21, 2019

Ayala Partnering with Novartis on Investigational AL102 for Treatment of Multiple Myeloma

News

In a new agreement, Ayala Pharmaceuticals will work with Novartis on the development and commercialization of AL102, an investigational treatment for multiple myeloma. The option-to-license deal calls for Ayala ... Read more

Posts by: Mary Chapman

Mary Chapman

Takeda Oncology Launches Myeloma Patient and Caregiver Mentorship Support Program

OncLive Poised to Induct 2019 Class of ‘Giants of Cancer Care’

bluebird bio Opens Manufacturing, Research Facility in Durham, N.C.

MMRF Launches Fund to Invest in Innovative Firms for Multiple Myeloma Research

It’s Off to the Races for eRace Cancer’s 78-year-old Founder and Multiple Myeloma Survivor

International Myeloma Foundation Gears Up for March, Myeloma Action Month

Multiple Myeloma Research Foundation Makes Changes in Leadership to Advance Precision Medicine

$75M Gift to Establish Center for Blood Cancers at NYU Langone Health Center

Donation Will Establish Center for Multiple Myeloma Research in UK

Ayala Partnering with Novartis on Investigational AL102 for Treatment of Multiple Myeloma

Pin It on Pinterest